TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
KPTI

Karyopharm Therapeutics Inc

Healthcare · Biotechnology

1.70$ -1.1% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

Karyopharm Therapeutics Inc (KPTI) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 111 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet KPTI
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
270 240 204 214 189 164 128 105 96 108 131 111
263 234 198 209 185 156 120 98 90 103 126 106
44 52 31 85 73 62 39 39 38 61 91 55
208 191 149 152 134 109 70 52 46 64 91 65
38 27 31 38 32 31 35 33 32 26 23 30
3.1 3.0 2.8 3.5 4.7 4.7 4.8 5.0 4.0 4.0 3.6 4.0
370 377 373 346 349 350 334 344 365 401 397 441
62 69 65 58 61 92 90 99 87 92 117 134
3.2 3.3 3.4 3.5 3.7 25 25 32 14 22 33 1.1
0.9 3.1 5.0 2.8 5.8 5.1 5.9 2.6 5.4 4.0 4.3 7.7
171 171 171 191 191 163 155 152 177 206 192 210
-100 -136 -169 -132 -160 -186 -206 -239 -269 -293 -266 -330
-1,445 -1,487 -1,524 -1,501 -1,533 -1,563 -1,587 -1,624 -1,657 -1,759 -1,782 -1,849
7.6 7.7 7.7 10 8.3 8.4 8.5 8.6 8.7 18 25 29

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?